Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
Proxima
Proxima Clinical ResearchProxima Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
Do published findings about Proxima match what happens in practice?
Public evidence
Proxima - AI Drug Discovery / Proximity-Based Medicines
Business Wire
Public evidence
Proxima Raises $80 Million Led by DCVC to Power the Next Generation of Proximity-Based Medicines - Business Wire
Business Wire
Public evidence
Proxima Raises $80 Million for AI Drug Discovery From DCVC, Nvidia - Bloomberg.com
Bloomberg.com
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 3 public external signal(s) across 2 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands Proxima through deployment evidence, company records and external market activity.
- Category
- uncategorized
What HealthAratus is still learning
HealthAratus is beginning to understand Proxima. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
Proxima is a healthcare AI tool. It is designed to process and reference signal data.According to Proxima Clinical Research
What Proxima Clinical Research states
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
Proxima provides references to specific signal data.
According to Proxima Clinical Research
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Reported outcome
Proxima Raises $80 Million Led by DCVC to Power the Next Generation of Proximity-Based Medicines - Business Wire
According to Business Wire
Are you seeing this result?
Reported outcome
Proxima Raises $80 Million for AI Drug Discovery From DCVC, Nvidia - Bloomberg.com
According to Bloomberg.com
Are you seeing this result?
Recent change
Proxima - AI Drug Discovery / Proximity-Based Medicines
According to Business Wire
Have you noticed this shift?
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
Proxima — healthcare AI tool referenced in 2 signal(s).
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in mixed settings
Parent Company
Proxima Clinical Researchvendor
How the reality here has changed
Not enough recorded activity across time yet to describe how the reality here has moved. As accounts of Proxima accumulate, this becomes a record of how the reality moved rather than a snapshot of one moment.
Connected intelligence
Category intelligence